Category Archives: Myocardial Infarction

Kyrgyzstan removes deaths caused by reasons other than COVID-19 from tally of lethal cases Representative image AKIPRESS.COM - Around 29% of lethal cases were not caused by COVID-19 or pneumonia, Deputy Health Minister Madamin Karataev told a press briefing today. Continue reading →

August 15, 2020 04:23 ET | Source: ReportLinker New York, Aug. 15, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cardiac Marker Testing Market Research Report by Type, by Product, by Disease, by Type of Testing - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913741/?utm_source=GNW The Global Cardiac Marker Testing Market is expected to grow from USD 2,976.65 Million in 2019 to USD 4,661.87 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.76%. Continue reading →

Cardiac Biomarker Market Research Report by Type (Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, and Troponins (T and I)), by Location of Testing (Laboratory Testing and Point of Care Testing), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 New York, Aug. 15, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cardiac Biomarker Market Research Report by Type, by Location of Testing, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913739/?utm_source=GNW The Global Cardiac Biomarker Market is expected to grow from USD 2,705.13 Million in 2019 to USD 5,893.05 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.85% Continue reading →

Background:Previous studies have suggested that abnormal sleep duration is associated with increased risk of metabolic syndrome (MetS). However, evidence on the association of sleep duration with stroke, myocardial infarction (MI) and tumors in populations with MetS is limited. Methods:A total of 8968 participants (2754 with MetS at baseline) were recruited in this retrospective study between March 2012 and December 2012. Continue reading →

A comprehensive protocol-based triaging and decision making at the point of care in patients with COVID-19 presenting with acute myocardial injury is necessary to reduce provider anxiety and confusion, offer a pathway for streamlined management of these challenging patients, while simultaneously minimizing the exposure of medical personnel to this highly contagious virus, according to a report published in Atherosclerosis. COVID-19 has forced the healthcare system to reconsider its approach to even the most basic practices Continue reading →

The report entitledGlobal Myocardial Infarction Treatment Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025highlights insights of market size, trends, share, growth, development plans, cost structure, and drivers analysis. The data which has been looked upon is included considering both, the existing top players and the upcoming competitors Continue reading →

The new research report titled Troponin Market published by Global Marketers into his huge database. Primary and secondary research methodologies have been used to formulate this report. This Report Provides an in-depth study analyzing the current and future demands of this market also it provides the overview, definition, cost structure, segmentation, recent developments, application,and industry chain analysis, CAGR growth, and Porters Five Forces Analysis, demand Continue reading →

INTRODUCTION Cardiovascular disease associated with myocardial infarction (MI) is a major cause of morbidity and mortality worldwide (1, 2). The heart is composed of dynamic and multicellular tissues that exhibit highly specific structural and functional characteristics. Continue reading →

Approximately one-third of young patients were found to have left ventricular systolic dysfunction after acute myocardial infarction (MI), of whom > 40% had ejection fraction (EF) recovery, according to a study published in the Journal of the American College of Cardiology. Left ventricular EF is a common tool used to identify patients who are at risk for adverse CV events and increased mortality after an acute MI Continue reading →

Background:Currently, the role of interleukin-10 (IL-10) as an anti-inflammatory factor in the occurrence and development of heart disease is still unclear. This study aimed to observe the dynamic changes in the expression of IL-10 in serum and myocardial tissues and to investigate the relationship of IL-10 expression with macrophage activation and cardiomyocyte apoptosis during the occurrence of myocardial infarction (MI) Continue reading →